ALK-IN-29 (compound 4c) exhibits notable inhibitory activity against tyrosine kinases such as ALK, CDK2/CyclinE1, and FAK, with the strongest inhibition observed against ALK kinase, showing a 40.63% inhibition rate at a concentration of 10 µM. ALK-IN-29 is useful for cancer research.
Molecular Weight:
504.42
CAS Number:
[2244986-40-9]
Formula:
C26H26BrN5O
Target:
CDK
T201159
* VAT and and shipping costs not included. Errors and price changes excepted
